Almost a year later, the country, which was the epicenter of the novel coronavirus has also emerged as a leader in the COVID-19 vaccines, a development that will enhance its standing as a global super power. Of the 40 new vaccines in clinical trials around the world, 11 are in China, the most of any country (as on September 25, 2020). Of the nine that are in Phase III, China has five. Chinese vaccines are expected to launch as early as December 2020.
Unlike western countries, which are hedging bets on the experimental vaccines, China is betting big on the tried and tested capabilities of inactivated vaccines. Five companies in the world that are pursuing inactivated coronavirus vaccines, four are Chinese, including Sinovac and two vaccines from state owned China National Pharmaceutical Group Co., Ltd. (Sinopharm). Earlier there were concerns about whether inactivated vaccines for the new coronavirus will work, but after AstraZeneca’s scandal in early September 2020 where the firm had to halt the trials because of adverse reaction, experts, now believe this old school method of vaccine might actually prove successful this time around as well.
While most of the Chinese companies are working independently, two of them - Fosun Pharma and Clover Biopharmaceuticals have partnered with international firms to develop the vaccine.
Fosun Pharma is partnering with US’ Pfizer and Germany’s BioNTech. In August 2020, BioNTech and Fosun Pharma announced the start of clinical trial of mRNA-based COVID-19 vaccine candidate in China.
Diese Geschichte stammt aus der October 2020-Ausgabe von BioSpectrum Asia.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der October 2020-Ausgabe von BioSpectrum Asia.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Ushering Fourth Industrial Revolution in Telangana
Taking advantage of the 21st edition of BioAsia 2024 at the Hyderabad International Convention Centre (HICC) in Madhapur, the Government of Telangana, a southern state in India, leveraged the confluence of the global platform to spearhead initiatives aimed at propelling the state into the forefront of the Fourth Industrial Revolution (C4IR).
How Indian Biotech Investments are on a Doubling Spree
A latest report by Ankur Capital provides a closer look at the investments made in biotechnology in the last decade in the country.
"AI will be integrally involved in not only the diagnosis of cancer but also in determining the prognosis and best therapeutic option”
South Korea-based Deep Bio, a pioneering artificial intelligence (AI) healthcare firm focused on cancer pathology, is making waves in the industry.
"Because of its specificity and selectivity, ADCS have the potential to reduce adverse side effects and improve patient survival"
Japan-headquartered Daiichi Sankyo, the global healthcare company, launched its subsidiary Daiichi Sankyo Singapore Pte. Ltd. to bridge unmet needs in oncology.
Can Test, Treat, Track Beat Malaria?
Malaria has long been a major public health concern in the Asia Pacific region, particularly in South East Asia (SEA) affecting millions of people.
Engineering CAR T cell sharpshooters
Approved CAR T-cell therapies have shown remarkable results in patients with certain types of blood cancers.
Addressing Challenges in Cell Therapy Manufacturing
Even with significant advancements, there are still anumber of issues with cell therapy manufacturing that need to be resolved as production grows.
"We anticipate India will adopt decentralised models for managing CGTs, ensuring closer proximity between patients and treatment facilities"
Cell and gene therapy (CGT) expert from Germany, Miltenyi Biotec has recently announced its entry into the Indian market to provide researchers, scientists and clinicians easier access to expertise, research, and manufacturing solutions.
Addressing Accessibility and Affordability of CELL & GENE THERAPIES
Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry.
Korea designs sweat resistant wearable robot sensor
New electromyography (EMG) sensor technology that allows the long-term stable control of wearable robots and is not affected by the wearer's sweat and dead skin has gained attention recently.